Current healthcare payment systems in the United States are all plagued by the problem of adverse incentivization. A more efficient system would be one which leaves billing entities uncertain of how a given patient encounter will be reimbursed.
TO THE EDITORS:
Current payment systems in United States healthcare are plagued by the problem of adverse incentivization. Capitated systems encourage providers to underutilize resources so as to maximize profit, potentially limiting patients’ access to useful medications or procedures. Fee-for-service systems encourage providers to overutilize resources, straining an already bloated healthcare budget and perversely rewarding poor outcomes that require subsequent costly treatment. A recently proposed reimbursement system—the accountable care organization (ACO)—seeks to mitigate the magnitude of adverse incentivization by combining system-wide capitation with provider-level quality and safety benchmarks.
While ongoing efforts to simultaneously maximize healthcare quality and minimize cost are to be applauded, early experiences from ACO trial sites have yielded mixed results.1 The ACO model may be equally unable to yield an optimal balance of quality and cost as traditional reimbursement models because, like those systems it is designed to replace, it fails to directly address the economic reasoning of ground-level healthcare providers. Savvy billing entities (providers, provider networks, or entire healthcare systems) with a comprehensive understanding of any reimbursement system will utilize that understanding to maximize profit within that system. It is the a priori knowledge of the reimbursement scheme’s methodology that creates a financial incentive for either underprovision or overprovision of care.
A more efficient system, which to my knowledge has not previously been proposed, would be one which leaves billing entities uncertain of how a given patient encounter will be reimbursed until after that encounter has been concluded. In such a system, a neutral and blinded third-party organization would randomly assign closed patient encounters to either fee-for-service payment or capitated payment. Because providers would not have been cognizant of the reimbursement scheme at the time of care provision, the only incentive for providers at point of contact would have been to provide the best and most judicious possible care to the patient.
Such a system, while purely theoretical, would not be prohibitively difficult to implement, as it could be built upon existing payment schemes. The system would be highly dependent upon the existence of a neutral and trustworthy third-party organization to adjudicate claims, but the underlying relationships between payers and providers would not need to be drastically altered. Until the issue of adverse incentivization is addressed at a more fundamental level, currently envisioned payment schemes may, by design, continue to yield suboptimal outcomes.Author Affiliations: Department of Surgery, University of Colorado- Denver, Aurora, CO.
Source of Funding: None reported.
Author Disclosures: The author reports no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this article.
Authorship Information: Concept and design; drafting of the manuscript; critical revision of the manuscript for important intellectual content.
Address correspondence to: David Paul Kuwayama, MD, MPA, Department of Surgery, University of Colorado-Denver, 12631 E 17th Ave, Mail Stop C312, Aurora, CO 80045. E-mail: david.kuwayama@ucdenver .edu1. Centers for Medicare & Medicaid Services. Pioneer Accountable Care Organizations succeed in improving care, lowering costs. http://www.cms.gov/Newsroom/MediaReleaseDatabase/Press- Releases/2013-Press-Releases-Items/2013-07-16.html. Published July 16, 2013. Accessed October 21, 2013.
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs
June 10th 2025Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Listen
Racial/Ethnic Differences in Colorectal Cancer Screening in the US
August 4th 2025Data from the 2021 National Health Interview Survey showed racial/ethnic differences in colorectal cancer screening were due to demographic and socioeconomic factors, except for low colonoscopy use in Asian individuals.
Read More
A meta-analysis showed that control group outcomes in psilocybin trials for depression were significantly weaker than those in selective serotonin reuptake inhibitor (SSRI) and esketamine trials, suggesting that psilocybin’s large observed treatment effects may be inflated by methodological factors such as functional unblinding and expectancy bias.
Read More
Trends in Insulin Out-of-Pocket Costs and Use Disparities, 2008-2021
July 31st 2025Given trends in cost and use, insulin out-of-pocket cost reduction policies would be more efficient if they targeted members in high-deductible health plans with savings options and low-income patients.
Read More